CERS Archived Articles
Cerus Corporation (NASDAQ:CERS): Positioning Itself as the Global Leader in Pathogen-Reduced Blood Products
Published on March 12, 2025
Cerus Corporation: A Steadfast Leader in Pathogen Reduction Technology
Published on November 17, 2024
Cerus Corporation (NASDAQ:CERS): Navigating the Pathogen Reduction Landscape with Resilience and Innovation
Published on September 24, 2024